rs114899765
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6BP7
The NM_000525.4(KCNJ11):c.567C>T(p.Ile189Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000515 in 1,612,068 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000525.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNJ11 | NM_000525.4 | c.567C>T | p.Ile189Ile | synonymous_variant | Exon 1 of 1 | ENST00000339994.5 | NP_000516.3 | |
KCNJ11 | NM_001166290.2 | c.306C>T | p.Ile102Ile | synonymous_variant | Exon 2 of 2 | NP_001159762.1 | ||
KCNJ11 | NM_001377296.1 | c.306C>T | p.Ile102Ile | synonymous_variant | Exon 3 of 3 | NP_001364225.1 | ||
KCNJ11 | NM_001377297.1 | c.306C>T | p.Ile102Ile | synonymous_variant | Exon 2 of 2 | NP_001364226.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000323 AC: 8AN: 247402Hom.: 0 AF XY: 0.0000373 AC XY: 5AN XY: 134060
GnomAD4 exome AF: 0.0000500 AC: 73AN: 1459766Hom.: 0 Cov.: 64 AF XY: 0.0000454 AC XY: 33AN XY: 726176
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74472
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge -
- -
not specified Uncertain:1
- -
Maturity onset diabetes mellitus in young Uncertain:1
Mutations in KCNJ11 gene can cause decreased production and secretion of insulin. This can lead to MODY which may be responsive to oral sulfonylureas. It is also associated with with Neonatal Diabetes. However, no sufficient evidence is found to ascertain the role of rs114899765 variant in MODY yet. -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at